2-Hydroxy-3-(2-hydroxy-3-methylbut-3-enyl)-4-methoxy-6-pentylbenzoic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Hydroxy-3-(2-hydroxy-3-methylbut-3-enyl)-4-methoxy-6-pentylbenzoic acid
• 化学式: C₁₈H₂₆O₅
• 分子量: 322.4
• InChiKey: VVHSBDYUNQCVOR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  23
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  87
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS
  申请人：DSM IP Assets B.V.

  公开号：EP2040696A2

  公开（公告）日：2009-04-01
• COMPOSITIONS COMPRISING ROSEHIP AND OTHER ACTIVE AGENTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
  申请人：DSM IP Assets B.V.

  公开号：EP2049134A2

  公开（公告）日：2009-04-22
• Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders
  申请人：Raederstorff Daniel

  公开号：US20080319071A1

  公开（公告）日：2008-12-25

  The present invention relates to new methoxylated aromatic compounds. It also relates to novel compositions comprising methoxylated aromatic compounds as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
• NOVEL COMPOSITIONS
  申请人：Raederstorff Daniel

  公开号：US20100055218A1

  公开（公告）日：2010-03-04

  The present invention relates to novel compositions comprising rosehip and at least one additional component e.g. selected from ligustilide, oleuropein (I), oleuropein aglycone (II), hydroxytyrosol, genistein, magnolol, honokiol, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
• US8158681B2
  申请人：——

  公开号：US8158681B2

  公开（公告）日：2012-04-17